Design and discovery of a highly potent ultralong-acting GLP-1 and glucagon co-agonist for attenuating renal fibrosis.
Zhao Q, Dong J, Liu H, Chen H, Yu H, Ye S, Yu S, Li Y, Qiu L, Song N, Xu H, Liu Q, Luo Z, Li Y, Wang R, Chen G, Jiang X.
Zhao Q, et al. Among authors: liu h, liu q.
Acta Pharm Sin B. 2024 Mar;14(3):1283-1301. doi: 10.1016/j.apsb.2023.11.020. Epub 2023 Nov 18.
Acta Pharm Sin B. 2024.
PMID: 38486997
Free PMC article.